DME Capital Management, LP

Superinvestor

Greenlight Capital

SEC CIK: 0001489933
Manager: David Einhorn
Style: Value, Hedge fund

SEC filings (opens in a new tab)

Previously filed asGREENLIGHT CAPITAL INC

IMVT holding history

Immunovant, Inc.

Every 13F filing in which Greenlight Capital reported holding IMVT, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.

IMVT overview All 13F holders of IMVT Full portfolio

DME Capital Management, LP: IMVT holding by quarter
Quarter	Shares	Value	% of portfolio	Change in shares	Action
Q2 2026	93,520	$3.6M	0.09%	00.0%	Unchanged
Q1 2026	93,520	$2.32M	0.07%	+93,520	New